Mary Gerrard

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Catherine Patte, Anne Aupérin, Mary Gerrard et al. · Blood · 2006 · 427 citations · Full text

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

Mitchell S. Cairo, Mary Gerrard, Richard Sposto et al. · Blood · 2006 · 359 citations · Full text

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study*

Mary Gerrard, Mitchell S. Cairo, Claire Weston et al. · British Journal of Haematology · 2008 · 198 citations

Hematological Malignancy, Lymphoid Neoplasia, B Nhl +15

Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor

Richard H. Scott, Jenny Douglas, Linda Baskcomb et al. · Nature Genetics · 2008 · 197 citations

Nonsyndromic Wilms Tumor, Developmental Anomaly, Developmental Biology +11

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

Mitchell S. Cairo, Richard Sposto, Mary Gerrard et al. · Journal of Clinical Oncology · 2012 · 181 citations · Full text